معرفی
Dr. James Stone is a Clinical Senior Lecturer at King’s College London, based in the Department of Neuroimaging within the Institute of Psychiatry, Psychology & Neuroscience (IoPPN). His research focuses on neurochemical mechanisms underlying mental illnesses, particularly schizophrenia, depression, and PTSD. He investigates how brain chemistry (e.g., glutamate, GABA) influences treatment responses and explores novel therapies like ketamine and psilocybin. His work also examines the gut microbiome’s role in mental health.
Recent research includes a study led by the IoPPN demonstrating potential benefits of probiotic supplementation for major depressive disorder. Dr. Stone’s projects, such as STRATA (Schizophrenia: Treatment Resistance and Therapeutic Advances), aim to improve understanding of symptom mechanisms and treatment personalization. His methodologies span clinical trials, neuroimaging (e.g., MRI), and psychological assessments.
